Ovensa Inc. Alternatives & Competitors

9 companies similar to Ovensa Inc. — Silencing galectin-1 overexpression in the tumor microenvironment.

ALX Oncology

ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boost...

63 IPO $525.20M

South San Francisco, Unit...

Biopharma Biotechnology +3

IO Biotech

Break Boundaries. Ignite Change.

91 Post-IPO Equity $198.00M

Denmark

Biotechnology Health Care +1

TransCode Therapeutics, Inc.

Delivering a cancer-free future

11 Post-IPO Equity $28.05M

Newton, United States

Biotechnology Health Care +1

Jounce Therapeutics, Inc.

Daring to create a world immune to cancer.

18 Post-IPO Equity $194.25M

Cambridge, United States

Biotechnology Health and Wellness +1

Track all Ovensa Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Arch Oncology

7 Series C $250.40M

Brisbane, United States

Biotechnology Health and Wellness

Tarveda Therapeutics

To discover, develop and commercialize a new class of potent and selective precision oncol...

5 $119.80M

Watertown, United States

Biotechnology Health Care +1

PanTher Therapeutics

A Quantum Leap Forward in the Fight Against Cancer

16 Non Equity Assistance $21.32M

Austin, United States

Biotechnology Health and Wellness

CRESCENDO BIOLOGICS LIMITED

Crescendo Biologics - The T cell Enhancing Company

62 Venture round $133.30M

Cambridge, United Kingdom

Biotechnology Health Care +1

Tango Therapeutics

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...

157 Post-IPO Equity $351.00M

Boston, United States

Biotechnology Health Care +1

Frequently Asked Questions

Companies similar to Ovensa Inc. include ALX Oncology, IO Biotech, TransCode Therapeutics, Inc., Jounce Therapeutics, Inc., Arch Oncology. They work in Biotechnology and Health and Wellness.

Bounce Watch lists 9 companies that share Ovensa Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Ovensa Inc. is a Canadian biotechnology startup founded in 2012 with a focus on advancing siRNA lead candidate to silence galectin-1 overexpression in the tumor microenvironment. Their main goal is to enhance the therapeutic outcomes of immuno-oncology anti-PD-1 checkpoint inhibitor as a combination therapy in head & n...

Don't just read about them. Follow them.

BounceWatch watches Ovensa Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Ovensa Inc. Profile ALX Oncology Alternatives IO Biotech Alternatives TransCode Therapeutics, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. The 9 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.